Company news

Anatara Lifesciences Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Anatara Lifesciences Ltd Receives Ethics Approval to Start IBS Trial

February 7, 2021

Anatara Lifesciences Ltd (ASX: ANR) R&D Tax Incentive Received

February 2, 2021

Anatara Lifesciences Ltd (ASX: ANR) Successful Poultry Trial

January 31, 2021

Anatara Lifesciences Ltd (ASX: ANR) Quarterly Cash Report

January 27, 2021

$1.4m raised through the completed SPP

November 16, 2020

SPP Offer Booklet

October 28, 2020

Completed Placement and announced Share Purchase Plan

October 20, 2020

Appendix 4E & Financial Report 30 June 2020

August 24, 2020

Partnering Update

June 23, 2020

Anatara Preclinical Program Summary

January 22, 2020

Anatara achieves preclinical milestone

December 19, 2019

Anatara reports statistically significant animal studies

October 13, 2019

Appendix 4E and Financial Report

August 27, 2019

Anatara Animal Health Assets Update

August 4, 2019

Anatara Animal Health Asset Update

June 28, 2019

Anatara retains global market for Detach

June 13, 2019

Response to ASX Appendix 4C Query

February 19, 2019

Successful proof of concept studies

February 7, 2019

R&D Tax Refund Received

January 13, 2019

Chief Executive Officer Appointment

November 13, 2018

APVMA approval for Detach

October 28, 2018

Appendix 4E & Audited Financial Statements

August 31, 2018

Investor Presentation and Strategy Update

July 18, 2018

Anatara CEO announces retirement

May 16, 2018

Exclusive Global License Agreement with Zoetis

May 15, 2018

FDA approves the Human Food Safety Dossier

February 4, 2018

R&D Tax Incentive Received

January 17, 2018

Pork CRC Options extended by 12 Months

September 12, 2017

Preliminary Final Report

August 30, 2017

ANR and Zoetis to negotiate International Detach Commercial

August 20, 2017

Investor Update and R&D Tax Rebate

June 5, 2017

Zoetis Second Payment is received

January 29, 2017

Investor Update

November 21, 2016

R&D Tax Refund

October 13, 2016

APVMA Submission Major Milestone Achieved

October 3, 2016

Successful Completion of Target Safety Study

September 7, 2016

Anatara Expands Executive Team

June 26, 2016

Anatara Trial Update

June 22, 2016

Milestone and Market Update

March 31, 2016

Zoetis Exclusive Research Evaluation and License Option

February 11, 2016

Second Successful Detach Trial

February 10, 2016

← Newer news releases

Decks

The 5 newest of 35 decks. Every deck is listed under its year.